Loading insider details...
Beta
Latest Form 4 (Nov 27, 2024): Exercise/Conversion of 25,219 VIRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 27, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |
| Sep 12, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |
| Jun 24, 2024 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 50,000 | n/a |
| May 29, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |
| Feb 27, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |
| Nov 28, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |
| Aug 29, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |
| Jun 9, 2023 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 40,000 | n/a |
| May 26, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |
| Feb 28, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 25,219 | n/a |